ABOUT
TEAM
PORTFOLIO
ASK
🇰🇷 KOR

kakaoventures blog

Deep insights, thoughtfully shared —
from Korea’s leading early-stage VC

See All ICT Service Deep Tech Digital Healthcare Game

Who Wins the U.S. Clinical AI Market? Abridge, Doximity, OpenEvidence, and Epic Go Head-to-Head

Who Wins the U.S. Clinical AI Market? Abridge, Doximity, OpenEvidence, and Epic Go Head-to-Head

Four AI companies are fighting to own U.S. clinical workflows. We break down how Abridge, Doximity, OpenEvidence, and Epic are building moats — and which formula wins.

Digital Healthcare

MCED FDA Approval Challenges: Why Multi-Cancer Blood Tests Remain Out-of-Pocket

MCED FDA Approval Challenges: Why Multi-Cancer Blood Tests Remain Out-of-Pocket

Why MCED tests haven't achieved FDA approval: Analysis of positive predictive value issues, clinical evidence barriers, and diagnostic costs. Plus market potential insights.

Digital Healthcare

HeartFlow IPO Analysis: Medical AI Company IPO Success Story

HeartFlow IPO Analysis: Medical AI Company IPO Success Story

HeartFlow's IPO marks the first pure-play medical AI company to reach public markets with 99% AI revenue. Analysis of business model, financials, and roadmap for medical AI startups.

Digital Healthcare

How At-Home Digital Diagnostics Are Reshaping Healthcare

How At-Home Digital Diagnostics Are Reshaping Healthcare

Discover how at-home digital diagnostics are enabling early detection and remote monitoring—reshaping the future of personalized healthcare.

Digital Healthcare

3 Unique Attributes of
Healthcare Business

3 Unique Attributes of Healthcare Business

What makes healthcare different from other industries? This article explores the sector’s core challenges—uncertainty, complexity, and high-mix, low-volume production.

Digital Healthcare

Who Wins the U.S. Clinical AI Market? Abridge, Doximity, OpenEvidence, and Epic Go Head-to-Head

Who Wins the U.S. Clinical AI Market? Abridge, Doximity, OpenEvidence, and Epic Go Head-to-Head

Four AI companies are fighting to own U.S. clinical workflows. We break down how Abridge, Doximity, OpenEvidence, and Epic are building moats — and which formula wins.

Digital Healthcare

MCED FDA Approval Challenges: Why Multi-Cancer Blood Tests Remain Out-of-Pocket

MCED FDA Approval Challenges: Why Multi-Cancer Blood Tests Remain Out-of-Pocket

Why MCED tests haven't achieved FDA approval: Analysis of positive predictive value issues, clinical evidence barriers, and diagnostic costs. Plus market potential insights.

Digital Healthcare

HeartFlow IPO Analysis: Medical AI Company IPO Success Story

HeartFlow IPO Analysis: Medical AI Company IPO Success Story

HeartFlow's IPO marks the first pure-play medical AI company to reach public markets with 99% AI revenue. Analysis of business model, financials, and roadmap for medical AI startups.

Digital Healthcare

How At-Home Digital Diagnostics Are Reshaping Healthcare

How At-Home Digital Diagnostics Are Reshaping Healthcare

Discover how at-home digital diagnostics are enabling early detection and remote monitoring—reshaping the future of personalized healthcare.

Digital Healthcare

3 Unique Attributes of
Healthcare Business

3 Unique Attributes of Healthcare Business

What makes healthcare different from other industries? This article explores the sector’s core challenges—uncertainty, complexity, and high-mix, low-volume production.

Digital Healthcare

Will AI-Based Opportunistic Screening in Medical Imaging Deliver Real-World Impact?

Will AI-Based Opportunistic Screening in Medical Imaging Deliver Real-World Impact?

AI-driven opportunistic screening promises early disease detection from routine scans—but real-world impact depends on insurance, outcomes, and system integration.

Digital Healthcare

Target Product Profiles: A Strategic Framework for Healthcare Startups

Target Product Profiles: A Strategic Framework for Healthcare Startups

Expertise and Strategic Thinking of Healthcare Startups

Digital Healthcare

kakaoventures

RSS·Powered by Inblog